Published in BMC Mol Biol on May 09, 2006
Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Res (2009) 4.11
Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation. Nucleic Acids Res (2008) 1.10
Regulation of Neph3 gene in podocytes--key roles of transcription factors NF-kappaB and Sp1. BMC Mol Biol (2009) 0.93
Regulation of podocalyxin expression in the kidney of streptozotocin-induced diabetic rats with Chinese herbs (Yishen capsule). BMC Complement Altern Med (2013) 0.92
Characterization of the human Activin-A receptor type II-like kinase 1 (ACVRL1) promoter and its regulation by Sp1. BMC Mol Biol (2010) 0.88
Specificity protein 1 (Sp1)-dependent activation of the synapsin I gene (SYN1) is modulated by RE1-silencing transcription factor (REST) and 5'-cytosine-phosphoguanine (CpG) methylation. J Biol Chem (2012) 0.86
Sp1 trans-activates and is required for maximal aldosterone induction of the αENaC gene in collecting duct cells. Am J Physiol Renal Physiol (2013) 0.86
Comparative analysis of the Shadoo gene between cattle and buffalo reveals significant differences. PLoS One (2012) 0.76
Glucose-induced gradual phenotypic modulation of cultured human glomerular epithelial cells may be independent of Wilms' tumor 1 (WT1). BMC Cell Biol (2013) 0.76
The role of DNA methylation in regulation of the murine Lhx3 gene. Gene (2013) 0.75
The Universal 3D3 Antibody of Human PODXL Is Pluripotent Cytotoxic, and Identifies a Residual Population After Extended Differentiation of Pluripotent Stem Cells. Stem Cells Dev (2016) 0.75
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A (1996) 29.54
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 18.36
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet (1998) 13.27
DNA methylation and human disease. Nat Rev Genet (2005) 12.00
Methylation-induced repression--belts, braces, and chromatin. Cell (1999) 9.89
WT-1 is required for early kidney development. Cell (1993) 7.05
Expression of the CD34 gene in vascular endothelial cells. Blood (1990) 4.41
Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol (1984) 3.91
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment. Blood (2002) 3.89
DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat Cell Biol (2004) 3.89
DNA methylation represses transcription in vivo. Nat Genet (1999) 2.92
Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium. Lab Invest (1977) 2.82
YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development (1999) 2.71
Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J Biol Chem (2004) 2.63
Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J Exp Med (2001) 2.45
Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res (2004) 1.90
Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: parallels to CD34. J Exp Med (1998) 1.81
Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin. J Biol Chem (1997) 1.58
Podocalyxin variants and risk of prostate cancer and tumor aggressiveness. Hum Mol Genet (2006) 1.46
Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors. J Cell Biol (1997) 1.39
Molecular cloning, expression, and characterization of podocalyxin-like protein 1 from rabbit as a transmembrane protein of glomerular podocytes and vascular endothelium. J Biol Chem (1995) 1.34
WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin. Curr Biol (2001) 1.31
Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin. Biochem Biophys Res Commun (2003) 1.29
Sulfate contributes to the negative charge of podocalyxin, the major sialoglycoprotein of the glomerular filtration slits. Proc Natl Acad Sci U S A (1991) 1.21
Glomerular epithelial alterations resulting from sialic acid surface coat removal. Kidney Int (1979) 1.20
Identification of a major sialoprotein in the glycocalyx of human visceral glomerular epithelial cells. J Clin Invest (1986) 1.13
Podocalyxin: a marker of blasts in acute leukemia. Am J Clin Pathol (2005) 1.06
Identification of podocalyxin-like protein 1 as a novel cell surface marker for hemangioblasts in the murine aorta-gonad-mesonephros region. Immunity (1999) 1.04
Cytosine methylation of an Sp1 site contributes to organ-specific and cell-specific regulation of expression of the lung epithelial gene t1alpha. Biochem J (2000) 1.00
Identification of endoglycan, a member of the CD34/podocalyxin family of sialomucins. J Biol Chem (2000) 0.99
Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine. J Biol Chem (1998) 0.98
Assignment of the human podocalyxin-like protein (PODXL) gene to 7q32-q33. Genomics (1997) 0.77
Modification of kidney barrier function by the urokinase receptor. Nat Med (2007) 4.01
Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology (2002) 2.49
Peginterferon plus ribavirin and sustained virological response in HCV-related cirrhosis: outcomes and factors predicting response. Am J Gastroenterol (2010) 1.59
Megakaryocyte gene targeting mediated by restricted expression of recombinase Cre. Thromb Haemost (2010) 1.39
Regulation of outside-in signaling in platelets by integrin-associated protein kinase C beta. J Biol Chem (2004) 1.32
Localization of the adhesion receptor glycoprotein Ib-IX-V complex to lipid rafts is required for platelet adhesion and activation. J Exp Med (2002) 1.20
Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity. Orphanet J Rare Dis (2013) 1.09
Disruption of the beta3 663-687 disulfide bridge confers constitutive activity to beta3 integrins. Blood (2003) 1.06
Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C. J Hepatol (2008) 1.05
Genetic variation responsible for mouse strain differences in integrin alpha 2 expression is associated with altered platelet responses to collagen. Blood (2004) 1.01
Response to steroids in de novo autoimmune hepatitis after liver transplantation. Hepatology (2002) 0.94
Platelets of female mice are intrinsically more sensitive to agonists than are platelets of males. Arterioscler Thromb Vasc Biol (2003) 0.92
L718P mutation in the membrane-proximal cytoplasmic tail of beta 3 promotes abnormal alpha IIb beta 3 clustering and lipid microdomain coalescence, and associates with a thrombasthenia-like phenotype. Haematologica (2010) 0.91
Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells. Exp Cell Res (2008) 0.89
Protein-protein interactions in platelet alphaIIbbeta3 signaling. Semin Thromb Hemost (2004) 0.88
HPV Direct Flow CHIP: a new human papillomavirus genotyping method based on direct PCR from crude-cell extracts. J Virol Methods (2013) 0.87
Involvement of ERK1/2, p38 and PI3K in megakaryocytic differentiation of K562 cells. Eur J Haematol (2010) 0.86
Oral leiomyoma: a case report. Med Oral (2003) 0.86
Type I Glanzmann thrombasthenia caused by an apparently silent beta3 mutation that results in aberrant splicing and reduced beta3 mRNA. Thromb Haemost (2005) 0.85
Disruption of the Cys5-Cys7 disulfide bridge in the platelet glycoprotein Ibbeta prevents the normal maturation and surface exposure of GPIb-IX complexes. Thromb Haemost (2003) 0.84
Release of podocalyxin into the extracellular space. Role of metalloproteinases. Biochim Biophys Acta (2011) 0.83
Ca2+/calmodulin-dependent modulation of cell cycle elements pRb and p27kip1 involved in the enhanced proliferation of lymphoblasts from patients with Alzheimer dementia. Neurobiol Dis (2003) 0.83
Possible role for cellular FXIII in monocyte-derived dendritic cell motility. Eur J Cell Biol (2009) 0.81
Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients. Thromb Haemost (2011) 0.81
A variant thrombasthenic phenotype associated with compound heterozygosity of integrin beta3-subunit: (Met124Val)beta3 alters the subunit dimerization rendering a decreased number of constitutive active alphaIIbbeta3 receptors. Thromb Haemost (2004) 0.80
Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth)). Thromb Haemost (2009) 0.79
Overexpression of podocalyxin in megakaryocytes and platelets decreases the bleeding time and enhances the agonist-induced aggregation of platelets. Thromb Res (2010) 0.79
C3G transgenic mouse models with specific expression in platelets reveal a new role for C3G in platelet clotting through its GEF activity. Biochim Biophys Acta (2012) 0.78
Ventricular enlargement associated with the panneural ablation of the podocalyxin gene. Mol Cell Neurosci (2009) 0.78
Type II Glanzmann thrombasthenia in a compound heterozygote for the alpha IIb gene. A novel missense mutation in exon 27. Haematologica (2006) 0.78
A child with mild X-linked intellectual disability and a microduplication at Xp22.12 including RPS6KA3. Pediatrics (2011) 0.78
Labour productivity losses caused by premature death associated with hepatitis C in Spain. Eur J Gastroenterol Hepatol (2015) 0.77
Diminished thrombogenic responses by deletion of the Podocalyxin Gene in mouse megakaryocytes. PLoS One (2011) 0.77
Nonsense mutation in exon-19 of GPIIb associated with thrombasthenic phenotype. Failure of GPIIb(delta597-1008) to form stable complexes with GPIIIa. Thromb Haemost (2002) 0.77
Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A. PLoS One (2012) 0.77
Variations in platelet protein associated with arterial thrombosis. Thromb Res (2008) 0.76
Control of cell adhesion and migration by podocalyxin. Implication of Rac1 and Cdc42. Biochem Biophys Res Commun (2013) 0.76
Generation of mice with conditional ablation of the Cd40lg gene: new insights on the role of CD40L. Transgenic Res (2013) 0.75
Detection and Genotyping of Human Papillomavirus DNA in Formalin-Fixed Paraffin-Embedded Specimens with the HPV Direct Flow CHIP System. Open Virol J (2013) 0.75
Effect of thrombopoietin-receptor agonists on a proliferation-inducing ligand (APRIL) plasma levels in patients with immune thrombocytopaenia. Br J Clin Pharmacol (2014) 0.75
alpha-Adrenergic-mediated activation of human reconstituted fibrinogen receptor (integrin alphaIIbbeta3) in Chinese hamster ovary cells. Thromb Haemost (2004) 0.75
[Epidemiological surveillance: a challenge for occupational health]. Arch Prev Riesgos Labor (2013) 0.75